Trade Summary

2 days ago, Sandler Laura Lee, serving as Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 5,000 shares at $91.82 per share, for a total transaction value of $459,101.20. Following this transaction, Sandler Laura Lee now holds 236,384 shares of ORKA.

This sale represents a 2.07% decrease in Sandler Laura Lee's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 at 6:36 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.